RUBY   $0.0899  -23.32% Market Closed

Rubius Therapeutics Inc
Total Cash 14.87M
totalCashPerShare 0.164
EBITDA -121.00M
Total Debt 1.10M
quickRatio 1.872
currentRatio 2.544
Total Revenue
debtToEquity 7.27
Revenue/Share
ROA -0.46633
ROE -1.85306
grossProfits
freeCashflow -85.37M
operatingCashflow -150.14M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -8.61M
forwardPE
floatShares 85.39M
sharesOutstanding 90.48M
sharesShort 1.53M
sharesShortPriorMonth 2.48M
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.05%
heldPercentInstitutions 0.00%
Short Ratio help_outline 0.49%
shortPercentOfFloat 0.04%
impliedSharesOutstanding
bookValue 0.167
Price To Book help_outline 0.34
earningsQuarterlyGrowth
netIncomeToCommon -179.67M
trailingEps -1.99%
forwardEps -0.98%
enterpriseToEbitda 0.07
lastDividendValue
lastDividendDate
currentQuarterEstimate 4Q 2022
institutionsCount 7
lastUpdated March 1, 2024, 4:24 a.m.